A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART

by Jackson AG, Kløverpris HN, Handley A, Hayes P, Gilmour J, Atkins M, Walker B, Ackland J, Sullivan M, Goulder P
Published 2012-09-01

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells

by Kløverpris H, Jackson A, Handley A, Hayes P, Gilmour J, Atkins M, Walker B, Ackland J, Sullivan M, Goulder P
Published 2012-09-01